Lamivudine Generics

Lamivudine, the active ingredient in Lamivudine Generics, is a nucleoside reverse transcriptase inhibitor presented as an oral dosage form for oral use. It is used to treat HIV infection and chronic hepatitis B in adult patients.

GNH USA supplies Lamivudine Generics as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality‑assured products that meet EU regulatory standards and providing reliable sourcing, regulatory documentation, and logistics support for global healthcare providers.

Lamivudine is an NRTI used in antiretroviral therapy and antiviral treatment of hepatitis B.

- HIV infection: reduces viral load and helps restore immune function when used in combination regimens. - Chronic hepatitis B: suppresses HBV DNA replication and improves liver enzyme profiles. - Prevention of mother‑to‑child transmission of HIV: lowers the risk of vertical transmission when administered to pregnant women alongside other antiretrovirals.

Lamivudine may cause a range of adverse reactions, most of which are mild to moderate.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Headache: transient cranial discomfort. - Fatigue: general tiredness. - Diarrhea: loose stools. - Insomnia: difficulty sleeping. - Rash: mild skin irritation.

Serious or Rare Side Effects: - Lactic acidosis: severe metabolic disturbance requiring immediate medical attention. - Pancreatitis: inflammation of the pancreas with abdominal pain. - Severe skin reactions: such as Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Hepatic failure: marked liver dysfunction. - Neutropenia: significant reduction in neutrophil count. - Anemia: decreased red blood cell levels.

When prescribing lamivudine, clinicians should consider several safety measures.

- Renal function monitoring: adjust dose in patients with impaired kidney function. - Hepatic function monitoring: watch for signs of liver toxicity. - Hepatitis B flare risk: monitor HBV DNA levels during therapy. - Hypersensitivity: discontinue if allergic reactions occur. - Pregnancy and lactation: use only if benefits outweigh potential risks. - Store at room temperature: keep in the original packaging, protect from moisture and direct sunlight.

Lamivudine can interact with several medications, requiring careful management.

Major Interactions (Avoid): - Didanosine: combined use increases risk of pancreatitis. - Stavudine: concurrent therapy may enhance mitochondrial toxicity. - Tenofovir: may exacerbate renal toxicity.

Moderate Interactions (Monitor Closely): - Rifampin: can lower lamivudine plasma concentrations. - Antacids containing aluminum or magnesium: may reduce oral absorption. - Warfarin: potential alteration of INR values, requiring closer monitoring.